Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that it has resumed shipments to reintroduce its intravenous iron replacement therapy INFeD. The product, which had been out of stock due to changes in the final product manufacturing site and issues with raw material supply, is re-entering the market earlier than expected. Watson expects to be in a normal supply situation for INFeD shortly.

Today in Popular Press...keeping you current

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/18/09

A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09

Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address